Most recent update: Friday, May 18, 2018 - 07:08

Bariatric News - Cookies & privacy policy

You are here

SurgiBot system

SurgiBot system completes pre-clinical sleeve gastrectomy

Multiple surgeons perform general surgery procedures in pre-clinical testing

Multiple surgeons have used TransEnterix’ SurgiBot patient-side minimally invasive robotic system to successfully complete a sleeve gastrectomy and cholecystectomy during pre-clinical testing.

“SurgiBot has promise as a patient-side robotic system for precise dissection during many types of surgical procedures,” said Professor Michel Gagner. “As an experienced laparoscopic surgeon, I appreciate the benefits of robotic precision, strength and ergonomics while remaining in control of the operative site in the sterile field. The system also allows the surgeon to control multiple instruments and a camera and therefore reduce reliance on other assistants during procedures.”

The SurgiBot is a minimally invasive, patient-side robotic surgery system. The system is designed to utilise a small incision and provides multiple channels to the surgeon capable of accommodating both rigid and flexible articulating instruments which offer dexterity in complex surgical tasks. The instruments are designed to give the surgeon needed strength and precision in an ergonomically comfortable manner while maintaining tactile feel.

SurgiBot also integrates high-definition, three-dimensional visualisation to restore the depth perception that’s lost in traditional laparoscopic procedures.

The system’s size and mobility are designed for easy repositioning during multi-quadrant surgery. As a patient-side robotic system, the surgeon maintains direct access to the sterile field throughout the procedure. By integrating the benefits of advanced technology and visualisation in a patient-side surgical system, TransEnterix believes the SurgiBot will advance minimally invasive surgery for patients, surgeons and hospitals.

“We’re pleased to have achieved this important milestone in the development of SurgiBot,” said Todd M Pope, president and CEO of TransEnterix. “We are committed to executing our plan of delivering a revolutionary patient-side robotic system to benefit patients, surgeons and hospitals.”

The company plans to submit a 510(k) application for clearance with the FDA for the SurgiBot system later in 2014.


Want more stories like this? Subscribe to Bariatric News!

Bariatric News
Keep up to date! Get the latest news in your inbox. NOTE: Bariatric News WILL NOT pass on your details to 3rd parties. However, you may receive ‘marketing emails’ sent by us on behalf of 3rd parties.